STUDY PROTOCOLS
Brief Intervention for Tobacco when Diagnosed with Oral Cancer (BITDOC): Study protocol of a randomized clinical trial studying efficacy of brief tobacco cessation intervention, Chhattisgarh, India
 
More details
Hide details
1
Department of Psychiatry, AIIMS, Raipur, India
2
Department of ENT & Head and Neck Surgery, AIIMS, Raipur, India
CORRESPONDING AUTHOR
Avinash Shukla   

Department of Psychiatry, AIIMS, Raipur Chhattisgarh, India
Publication date: 2020-01-15
Submission date: 2019-09-29
Final revision date: 2019-11-29
Acceptance date: 2019-12-03
 
Tob. Prev. Cessation 2020;6(January):4
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Tobacco use is a major causative factor for cancer. Cessation programs along with diagnosis of cancer as a motivating factor may improve quitting rates in patients. This is a protocol of a study that aims to assess the efficacy of brief tobacco cessation intervention (compared to treatment as usual, TAU) on pattern and attitudes towards tobacco chewing in newly diagnosed head and neck cancer patients and their relatives.

Methods:
The proposed study will be conducted in two phases. Phase 1 will include 105 dyads of patients and relatives and shall assess patterns (amount, frequency, duration of use and dependence etc.) and knowledge and attitudes (quitting, continued use, health-behavioural modifications, long-term effects on treatment etc.) towards tobacco chewing in newly diagnosed head and neck cancer patients using smokeless tobacco and their relatives. Sample will be recruited from outpatients attending the ear, nose, throat and head and neck surgery department of a tertiary health care institute. Phase 2 will be a randomized trial that will compare the efficacy of the ‘Brief Intervention for Tobacco when Diagnosed with Oral Cancer’ (BITDOC) and TAU, and will include 27 dyads in each of the two groups. Intervention will be delivered in three sessions, based on the principles of motivational interviewing and the 3As model.

Conclusions:
This study will help in the evaluation of the attitude towards smokeless tobacco (SLT) in a population that has faced the adverse consequences from its use and changes brought by a diagnosis of HNC. It will also help in developing a cost-effective model for promotion of smoking cessation.

CONFLICTS OF INTEREST
The authors have each completed and submitted an ICMJE form for disclosure of potential conflicts of interest. The authors declare that they have no competing interests, financial or otherwise, related to the current work. All authors report that this research received funding from Chhattisgarh State Planning Commission.
FUNDING
This research received funding from Chhattisgarh State Planning Commission, 1387/SPC/SNo/2017-18 Dt 28/11/2018.
PROVENANCE AND PEER REVIEW
Not commissioned; externally peer reviewed.
 
REFERENCES (45)
1.
Burris JL, Studts JL, DeRosa AP, Ostroff JS. Systematic Review of Tobacco Use after Lung or Head/Neck Cancer Diagnosis: Results and Recommendations for Future Research. Cancer Epidemiol Biomarkers Prev. 2015;24(10):1450-1461. doi:10.1158/1055-9965.EPI-15-0257
 
2.
Choi SH, Terrell JE, Bradford CR, Ghanem T, Spector ME, Wolf GT et al. Does Quitting Smoking Make a Difference Among Newly Diagnosed Head and Neck Cancer Patients? Nicotine Tob Res. 2016;18(12):2216-2224. doi:10.1093/ntr/ntw189
 
3.
Garces YI, Yang P, Parkinson J, Zhao X, Wampfler JA, Ebbert JO et al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest. 2004;126(6):1733-1741. doi:10.1378/chest.126.6.1733
 
4.
Petros WP, Younis IR, Ford JN, Weed SA. Effects of tobacco smoking and nicotine on cancer treatment. Pharmacotherapy. 2012;32(10):920-931. doi:10.1002/j.1875-9114.2012.01117
 
5.
Edwards B, Clarke V. The psychological impact of a cancer diagnosis on families: the influence of family functioning and patients' illness characteristics on depression and anxiety. Psychooncology. 2004;13(8):562-576. doi:10.1002/pon.773
 
6.
McBride CM, Ostroff JS. Teachable moments for promoting smoking cessation: the context of cancer care and survivorship. Cancer Control. 2003;10(4):325-333. doi:10.1177/107327480301000407
 
7.
Davidson SM, Boldt RG, Louie AV. How can we better help cancer patients quit smoking? The London Regional Cancer Program experience with smoking cessation. Curr Oncol. 2018;25(3):226-230. doi:10.3747/co.25.3921
 
8.
Nayan S, Gupta M, Sommer DD. Evaluating smoking cessation interventions and cessation rates in cancer patients: a systematic review and meta-analysis. ISRN Oncol. 2011;2011:849023. doi:10.5402/2011/849023
 
9.
Nayan S, Gupta MK, Strychowsky JE, Sommer DD. Smoking cessation interventions and cessation rates in the oncology population: an updated systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2013;149(2):200-211. doi:10.1177/0194599813490886
 
10.
Lucchiari C, Masiero M, Botturi A, Pravettoni G. Helping patients to reduce tobacco consumption in oncology: a narrative review. Springerplus. 2016;5(1):1136. doi:10.1186/s40064-016-2798-9
 
11.
Klemp I, Steffenssen M, Bakholdt V, Thygesen T, Sørensen JA. Counseling is Effective for Smoking Cessation in Head and Neck Cancer Patients-A Systematic Review and Meta-Analysis. J Oral Maxillofac Surg. 2016;74(8):1687-1694. doi:10.1016/j.joms.2016.02.003
 
12.
McCarter K, Martínez Ú, Britton B, Baker A, Bonevski B, Carter G, Beck A, Wratten C, Guillaumier A, Halpin SA, Wolfenden L. Smoking cessation care among patients with head and neck cancer: a systematic review. BMJ Open. 2016;6(9):e012296. doi:10.1136/bmjopen-2016-012296
 
13.
Shingler E, Robles LA, Perry R, Penfold C, Ness AR, Thomas S, et al. Systematic review evaluating randomized controlled trials of smoking and alcohol cessation interventions in people with head and neck cancer and oral dysplasia. Head Neck. 2018;40(8):1845-1853. doi:10.1002/hed.25138
 
14.
Stanislaw AE, Wewers ME. A smoking cessation intervention with hospitalized surgical cancer patients: a pilot study. Cancer Nurs. 1994;17(2):81-86. doi:10.1097/00002820-199404000-00001
 
15.
Griebel B, Wewers ME, Baker CA. The effectiveness of a nurse-managed minimal smoking-cessation intervention among hospitalized patients with cancer. Oncol Nurs Forum. 1998;25(5):897-902. PMID:9644706.
 
16.
Schnoll RA, Zhang B, Rue M, Krook JE, Spears WT, Marcus AC et al. Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol. 2003;21(2):355-365. doi:10.1200/JCO.2003.04.122
 
17.
Wakefield M, Olver I, Whitford H, Rosenfeld E. Motivational interviewing as a smoking cessation intervention for patients with cancer: randomized controlled trial. Nurs Res. 2004;53(6):396-405. doi:10.1097/00006199-200411000-00008
 
18.
Schnoll RA, Rothman RL, Wielt DB, Lerman C, Pedri H, Wang H et al. A randomized pilot study of cognitive-behavioral therapy versus basic health education for smoking cessation among cancer patients. Ann Behav Med. 2005;30(1):1-11. doi:10.1207/s15324796abm3001_1
 
19.
Schnoll RA, Martinez E, Tatum KL, Weber DM, Kuzla N, Glass M, et al. A bupropion smoking cessation clinical trial for cancer patients. Cancer Causes Control. 2010;21(6):811-820. doi:10.1007/s10552-010-9507-8
 
20.
Thomsen T, Tønnesen H, Okholm M, Kroman N, Maibom A, Sauerberg ML, et al. Brief smoking cessation intervention in relation to breast cancer surgery: a randomized controlled trial. Nicotine Tob Res. 2010;12(11):1118-1124. doi:10.1093/ntr/ntq158
 
21.
Ostroff JS, Burkhalter JE, Cinciripini PM, Li Y, Shiyko MP, Lam CY, et al. Randomized trial of a presurgical scheduled reduced smoking intervention for patients newly diagnosed with cancer. Health Psychol. 2014;33(7):737-747. doi:10.1037/a0033186
 
22.
Gritz ER, Carr CR, Rapkin D, Abemayor E, Chang LJ, Wong WK, et al. Predictors of long‐term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 1993;2(3):261‐270. PMID:8318879.
 
23.
Duffy SA, Ronis DL, Valenstein M, Lambert MT, Fowler KE, Gregory L et al. A tailored smoking, alcohol, and depression intervention for head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2203-2208. doi:10.1158/1055-9965.EPI-05-0880
 
24.
Ghosh A, Philiponis G, Bewley A, Ransom ER, Mirza N. You can't pay me to quit: the failure of financial incentives for smoking cessation in head and neck cancer patients. J Laryngol Otol. 2016;130(3):278‐283. doi:10.1017/S0022215116000037
 
25.
Koca D, Oztop I, Yilmaz U. Evaluation of changes in the attitudes and behaviors of relatives of lung cancer patients toward cancer prevention and screening. Indian J Cancer. 2013;50(3):233-238. doi:10.4103/0019-509X.118740
 
26.
Sarna L, Cooley M, Brown J, Williams R, Chernecky C, Padilla G, et al. Quality of Life and Health Status of Dyads of Women With Lung Cancer and Family Members. Oncol Nurs Forum. 2006;33:1109-1116. doi:10.1188/06.ONF.1109-1116
 
27.
Schnoll R, Malstrom M, James C, Rothman R, Miller S, Ridge J, et al. Correlates of tobacco use among smokers and recent quitters diagnosed with cancer. Patient Educ Couns. 2002;46(2):137-145. doi:10.1016/S0738-3991(01)00157-4
 
28.
Weaver KE, Rowland JH, Augustson E, Atienza AA. Smoking Concordance in Lung and Colorectal Cancer Patient-Caregiver Dyads and Quality of Life. Cancer Epidemiol Biomarkers Prev. 2011;20(2):239-248. doi:10.1158/1055-9965.EPI-10-0666
 
29.
Patten CA, Boyle R, Tinkelman D, Brockman TA, Lukowski A, Decker PA, et al. Linking smokers to a quitline: randomized controlled effectiveness trial of a support person intervention that targets non-smokers. Health Educ Res. 2017;32(4):318-331. doi:10.1093/her/cyx050
 
30.
McCarthy MJ, Craddock WS, Acquavita SP, Black K. A mixed-methods study of smoking attitudes and behaviors among dual-smoker stroke survivor–caregiver dyads. J Health Psychol. 2016;23(13):1659-1667. doi:10.1177/1359105316667797
 
31.
Chan S, Cheung YTD, Fong D, Emmons K, Leung A, Leung D, et al. Family-Based Smoking Cessation Intervention for Smoking Fathers and Nonsmoking Mothers with a Child: A Randomized Controlled Trial. J Pediatr. 2016;182:260-266.e4. doi:10.1016/j.jpeds.2016.11.021
 
32.
Gururaj G, Varghese M, Benegal V. National Mental Health Survey, Chhattisgarh State Report 2015-16: Prevalence, Pattern and Outcomes. http://indianmhs.nimhans.ac.in.... Accessed July 22, 2019.
 
33.
World Health Organization. Global Adult Tobacco Survey: Fact sheet, Chhattisgarh 2016-17. http://www.tiss.edu/uploads/fi.... Accessed July 22, 2019.
 
34.
Indian Council of Medical Research. Tobacco related cancers. In: Consolidated Report of the HBCRs: 2012-2014. http://www.ncdirindia.org/ncrp.... Accessed July 22, 2019.
 
35.
Gupta B, Johnson NW. Systematic review and meta-analysis of association of smokeless tobacco and of betel quid without tobacco with incidence of oral cancer in South Asia and the Pacific. PLoS One. 2014;9(11):e113385. doi:10.1371/journal.pone.0113385
 
36.
Miller WR, Rollnick S. Motivational Interviewing: Preparing People for change. New York, NY: The Guilford Press; 2002.
 
37.
Reid RD, Mullen K-A, Slovinec D’Angelo ME, Aitken DA, Papadakis S, Haley PM, et al. Smoking cessation for hospitalized smokers: An evaluation of the “Ottawa Model.” Nicotine Tob Res. 2010;12(1):11-18. doi:10.1093/ntr/ntp165
 
38.
Papadakis S, Cole AG, Reid RD, Coja M, Aitken D, Mullen K-A, et al. Increasing Rates of Tobacco Treatment Delivery in Primary Care Practice: Evaluation of the Ottawa Model for Smoking Cessation. Ann Fam Med. 2016;14(3):235-243. doi:10.1370/afm.1909
 
39.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: A revision of the Fagerström tolerance questionnaire. Br J Addict. 1991;86(9):1119-1127. doi:10.1111/j.1360-0443.1991.tb01879.x
 
40.
Ebbert JO, Patten CA, Schroeder DR. The Fagerström Test for Nicotine Dependence-Smokeless Tobacco (FTND-ST). Addict Behav. 2006;31(9):1716-1721. doi:10.1016/j.addbeh.2005.12.015
 
41.
Ahsan M, Saad M, Jawed M, Akhtar S, Haseeb A, Bilal M, Ahmed A. Impact of tobacco health warnings on smokers in Pakistan. J Pak Med Assoc. 2016; 66(1):59-62. PMID:26712183.
 
42.
Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK et al. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017.
 
43.
Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel, Jr EL. Prognostic Importance of Comorbidity in a Hospital-Based Cancer Registry. JAMA. 2004;291(20):2441-2447. doi:10.1001/jama.291.20.2441
 
44.
Deshpande NC, Nawathe AA. Translation and validation of Hindi version of Oral Health Impact Profile-14. J Indian Soc Periodontol. 2015;19(2):208-210. doi:10.4103/0972-124X.145806
 
45.
Slade GD. Derivation and validation of a short-form oral health impact profile. Community Dent Oral Epidemiol. 1997;25(4):284-290. doi:10.1111/j.1600-0528.1997.tb00941
 
eISSN:2459-3087